Table 1.
Modality | Timepoint | n | Structure | Metric | Odds ratio | 95% Confidence interval | P-value |
---|---|---|---|---|---|---|---|
Perfusion | Before treatment | 88 | Lungs-GTV | Volume, cc | 1.02– | 0.50–2.01 | .95 |
V20, % | 1.05– | 0.94–1.17 | .39 | ||||
ADL, Gy | 1.12– | 1.02–1.25 | .02 | ||||
iV20, a.u. | 0.08– | 0.01–0.91 | .05 | ||||
Ipsilateral lung-GTV | Volume, cc | 0.85– | 0.16–4.05 | .84 | |||
V20, % | 1.01– | 0.96–1.07 | .66 | ||||
ADL, Gy | 1.05– | 1.00–1.10 | .07 | ||||
iV20, a.u. | 0.05– | 0.00–0.69 | .03 | ||||
Contralateral lung-GTV | Volume, cc | 0.91– | 0.25–2.97 | .87 | |||
V20, % | 1.00– | 0.86–1.15 | .95 | ||||
ADL, Gy | 1.52– | 1.06–2.23 | .03 | ||||
iV20, a.u. | 0.82– | 0.13–4.88 | .83 | ||||
Ventilation | Before treatment | 88 | Lungs-GTV | Volume, cc | 1.00– | 0.49–1.98 | .99 |
V20, % | 1.06– | 0.95–1.19 | .29 | ||||
ADL, Gy | 1.14– | 1.03–1.26 | .01 | ||||
iV20, a.u. | 0.06– | 0.00–0.64 | .02 | ||||
Ipsilateral lung-GTV | Volume, cc | 0.87– | 0.17–3.99 | .86 | |||
V20, % | 1.02– | 0.97–1.08 | .39 | ||||
ADL, Gy | 1.05– | 1.00–1.10 | .08 | ||||
iV20, a.u. | 0.06– | 0.00–0.61 | .03 | ||||
Contralateral lung-GTV | Volume, cc | 1.47– | 0.41–5.10 | .54 | |||
V20, % | 0.99– | 0.85–1.12 | .88 | ||||
ADL, Gy | 1.36– | 0.92–2.01 | .12 | ||||
iV20, a.u. | 1.24– | 0.15–9.27 | .83 |
Abbreviations: ADL = average dose to the lower region of lung structure in Gy; GTV = gross tumor volume; iV20 = average normalized functional intensity receiving ≥20 Gy in arbitrary units; V20 = volume of lung structure receiving ≥20 Gy as a percent of total lung structure volume; volume = normal lung volume excluding GTV.